Categories

95 pages

Exclusive Analysis

Tech Leaders’ Money in Biotech Reached Public Stocks First Through Acquisitions and Narratives: A Map of 94 Companies and a Review of U.S. and Korean Listed Companies

Semiconductor Suppliers Rallied Sharply, but Only a Fraction of Large-Cap Selling Followed: Reviewing Entry Order Across the Value Chain

Compute Gets Cheaper While Memory Accumulates: Why Korean Memory Is Adding Logic in the Agent Era

When AI Bottlenecks Re-rate: Pricing and Cash Separate Samsung Electro-Mechanics, Seagate, and Ciena

The U.S. AI-Biotech Rally: Why Proteina, GC Genome, and ST Pharm Need Separate Cases in Korea

After Micron’s Strong Results, Korean Semiconductor Stocks Face a Test of Earnings Growth and Durability

Why U.S. Stocks Hold Up at 5% Yields: Earnings and Concentration

The Korea-US Investment Deal and the Westinghouse Repricing: A Paired Idea in Cameco and Doosan Enerbility

The Day CPUs Rallied Again: From the US Session to Korea's Substrate Names

The US 400GW Nuclear Plan and the Westinghouse Stake Negotiations: The Opportunity for Korea, and the Expectations Already Priced In